Drug shortages - A critical challenge for the generic-drug market

New England Journal of Medicine

Volumn 365, Issue 23, 2011, Pages 2147-2149

  Chabner, Bruce A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; CAPECITABINE; CISPLATIN; CYTARABINE; DOXORUBICIN; ELECTROLYTE; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GENERIC DRUG; IRINOTECAN; METHOTREXATE; PACLITAXEL; VINCRISTINE; VITAMIN;

CANCER CHEMOTHERAPY; COLORECTAL CANCER; DRUG CONTAMINATION; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SHORTAGE; DRUG SUBSTITUTION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; LAW; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MEDICARE; NEOPLASM; ONCOLOGY; PHARMACY; PRIORITY JOURNAL; PROFIT; SHORT SURVEY;

EID: 83155188464     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1112633     Document Type: Short Survey

References (4)

1. Food and Drug Administration. Drug shortages (http://www.fda.gov/Drugs/ DrugSafety/DrugShortages).
2. Pharmacy Blog. Why a Boehringer unit really has drug shortages. June 13, 2011 (http://pharmacyblogbuy.com/tag/ bedford-laboratories).
3. Centers for Medicare and Medicaid Services. Medicare Part B drugs regulations (http://www.cms.gov/McrPartBDrugAvgSales Price/03-regulations.asp).
4. Reuters. Cancer drug sales could hit $80 billion by 2011: IMS. May 15, 2008 (http://www.reuters.com/article/2008/05/15/ us-cancer-forecast- idUSN1453543620080515).